IVM & ICSI weight, height and cranial circumference according to sex.

<p>*Comparison between IVM and ICSI. Kruskal Wallis test.</p

Characteristics of Mothers and Pregnancies N = 68.

<p>Control : ICSI without IVM.</p

Characteristics of Infants at birth.

<p>Characteristics of Infants at birth.</p

IVM & ICSI Outcomes at 1 year and two years.

<p>IVM & ICSI Outcomes at 1 year and two years.</p

Associations between sleep complaints and future CVD (CHD or Stroke) events over 6-year follow-up.

<p>Model 0 was adjusted for center and gender.</p><p>Model 1 was adjusted for model 0 plus mobility, respiratory disease, depressive symptoms, Body Mass Index, hypertension, diabetes mellitus.</p><p>Model 2 was adjusted for model 1 plus prescribed sleep medication.</p><p>Model 3 was adjusted for model 2 plus past-history of cerebro-cardio vascular disease (stroke or CHD).</p>(a)<p>number of insomnia symptoms.</p>(b)<p>Difficulty with initiating sleep.</p>(c)<p>Difficulty in maintaining sleep.</p>(d)<p>Early morning awakening.</p>(e)<p>Excessive daytime sleepiness.</p

Relationships between past-history of CVD (stroke or CHD) and sleep complaints evaluated at baseline.

(a)<p>odds ratio (OR) for the presence of the sleep complaint indicated. The OR gives the risk of presenting a sleep complaint among those with a past-history of CVD compared to those without a past-history of CVD. The reference (OR = 1) corresponds to the subjects without the sleep complaint indicated.</p><p>Model 1 was adjusted for center, age and gender.</p><p>Model 2: Model 1 adjusted for educational level, living alone, mobility, alcohol intake, caffeine intake, smoking status, respiratory disease, thyroid disease, depressive symptoms, BMI, hypertension, diabetes mellitus, hypercholesterolemia, loudly snoring.</p><p>Model 3: Model 2 adjusted for prescribed sleep medication.</p><p>Model 4: Number of insomnia complaints, DIS, DMS and EMA were adjusted for variables of Model 3 plus EDS. EDS was adjusted for the Model 3 plus the number of insomnia complaints.</p

Flow diagram.

<p>Flow diagram.</p

Baseline predictors of CVD (CHD or Stroke) events during the follow-up.

(a)<p>Adjustment for center and gender.</p

Baseline sociodemographic and clinical characteristics of participants according to sleep symptoms (Excessive daytime sleepiness (EDS) and number of insomnia complaints) evaluated at baseline.

(a)<p>Adjustment for age, center and gender.</p>(b)<p>high vs low ^(c) yes vs no ^(d) past/current vs never ^(e) <26 vs ≥26 ^(f) frequently/often vs never/rarely.</p

Demographics of the study population (<i>n</i> = 697).

<p>Demographics of the study population (<i>n</i> = 697).</p